Sachdeva, Anand Kamal, Kuhad, Anurag, Tiwari, Vinod et al. · Basic & clinical pharmacology & toxicology · 2010 · DOI
This study tested whether a compound from green tea called EGCG could help reduce fatigue in mice exposed to stress. Researchers induced fatigue-like symptoms in mice through daily forced swimming, then gave some mice EGCG supplements. The treatment appeared to reduce the mice's fatigue and also lowered harmful inflammation markers in their brains.
This study explores a potential biological mechanism underlying ME/CFS—oxidative stress and neuroinflammation—using a natural, well-tolerated compound. If findings translate to humans, EGCG (an abundant green tea polyphenol) could represent an accessible, low-risk therapeutic avenue worth clinical investigation.
This study does not prove EGCG works in ME/CFS patients; animal models of stress-induced fatigue are imperfect proxies for the human disease. The findings are correlative within the mouse model and do not establish that reducing oxidative stress or TNF-α is the primary mechanism of human ME/CFS fatigue, nor do they demonstrate efficacy, safety, or optimal dosing in clinical populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.